NooN L. Prophylactic inoculation against hay fever. Int Arch Allergy Appl Immunol. 1953. 4(4):285-8. [QxMD MEDLINE Link].
Durham SR, Ying S, Varney VA, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol. 1992 Apr 15. 148(8):2390-4. [QxMD MEDLINE Link].
Marshall JS. Mast-cell responses to pathogens. Nat Rev Immunol. 2004 Oct. 4(10):787-99. [QxMD MEDLINE Link].
Nouri-Aria KT, Irani AM, Jacobson MR, et al. Basophil recruitment and IL-4 production during human allergen-induced late asthma. J Allergy Clin Immunol. 2001 Aug. 108(2):205-11. [QxMD MEDLINE Link].
Kay AB, Barata L, Meng Q, Durham SR, Ying S. Eosinophils and eosinophil-associated cytokines in allergic inflammation. Int Arch Allergy Immunol. 1997 May-Jul. 113(1-3):196-9. [QxMD MEDLINE Link].
Kinet JP. The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu Rev Immunol. 1999. 17:931-72. [QxMD MEDLINE Link].
Prussin C, Metcalfe DD. 5. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol. 2006 Feb. 117(2 Suppl Mini-Primer):S450-6. [QxMD MEDLINE Link].
Ying S, Barata LT, Meng Q, Grant JA, Barkans J, Durham SR, et al. High-affinity immunoglobulin E receptor (Fc epsilon RI)-bearing eosinophils, mast cells, macrophages and Langerhans' cells in allergen-induced late-phase cutaneous reactions in atopic subjects. Immunology. 1998 Feb. 93(2):281-8. [QxMD MEDLINE Link]. [Full Text].
Gaga M, Frew AJ, Varney VA, Kay AB. Eosinophil activation and T lymphocyte infiltration in allergen-induced late phase skin reactions and classical delayed-type hypersensitivity. J Immunol. 1991 Aug 1. 147(3):816-22. [QxMD MEDLINE Link].
Garcia BE, Sanz ML, Gato JJ, Fernandez J, Oehling A. IgG4 blocking effect on the release of antigen-specific histamine. J Investig Allergol Clin Immunol. 1993 Jan-Feb. 3(1):26-33. [QxMD MEDLINE Link].
Iliopoulos O, Baroody FM, Naclerio RM, Bochner BS, Kagey-Sobotka A, Lichtenstein LM. Histamine-containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils. J Immunol. 1992 Apr 1. 148(7):2223-8. [QxMD MEDLINE Link].
Sampson AP. The role of eosinophils and neutrophils in inflammation. Clin Exp Allergy. 2000 Jun. 30 Suppl 1:22-7. [QxMD MEDLINE Link].
Royer B, Varadaradjalou S, Saas P, Guillosson JJ, Kantelip JP, Arock M. Inhibition of IgE-induced activation of human mast cells by IL-10. Clin Exp Allergy. 2001 May. 31(5):694-704. [QxMD MEDLINE Link].
Francis JN, James LK, Paraskevopoulos G, Wong C, Calderon MA, Durham SR, et al. Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J Allergy Clin Immunol. 2008 May. 121(5):1120-1125.e2. [QxMD MEDLINE Link].
Finegold I, Oppenheimer J. Immunotherapy: the next 100 years. Ann Allergy Asthma Immunol. 2010 Nov. 105(5):394-8. [QxMD MEDLINE Link].
Dunsky EH, Goldstein MF, Dvorin DJ, Belecanech GA. Anaphylaxis to sublingual immunotherapy. Allergy. 2006 Oct. 61(10):1235. [QxMD MEDLINE Link].
Antico A, Pagani M, Crema A. Anaphylaxis by latex sublingual immunotherapy. Allergy. 2006 Oct. 61(10):1236-7. [QxMD MEDLINE Link].
Eifan AO, Keles S, Bahceciler NN, Barlan IB. Anaphylaxis to multiple pollen allergen sublingual immunotherapy. Allergy. 2007 May. 62(5):567-8. [QxMD MEDLINE Link].
Blazowski L. Anaphylactic shock because of sublingual immunotherapy overdose during third year of maintenance dose. Allergy. 2008 Mar. 63(3):374. [QxMD MEDLINE Link].
de Groot H, Bijl A. Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet. Allergy. 2009 Jun. 64(6):963-4. [QxMD MEDLINE Link].
Cochard MM, Eigenmann PA. Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy. J Allergy Clin Immunol. 2009 Aug. 124(2):378-9. [QxMD MEDLINE Link].
Glover MT, Atherton DJ. A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema. Clin Exp Allergy. 1992 Apr. 22(4):440-6. [QxMD MEDLINE Link].
Werfel T, Breuer K, Ruéff F, Przybilla B, Worm M, Grewe M, et al. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy. 2006 Feb. 61(2):202-5. [QxMD MEDLINE Link].
Silny W, Czarnecka-Operacz M. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study]. Pol Merkur Lekarski. 2006 Dec. 21(126):558-65. [QxMD MEDLINE Link].
Cadario G, Galluccio AG, Pezza M, Appino A, Milani M, Pecora S, et al. Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study. Curr Med Res Opin. 2007 Oct. 23(10):2503-6. [QxMD MEDLINE Link].
Pajno GB, Caminiti L, Vita D, Barberio G, Salzano G, Lombardo F, et al. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol. 2007 Jul. 120(1):164-70. [QxMD MEDLINE Link].
Bussmann C, Maintz L, Hart J, Allam JP, Vrtala S, Chen KW, et al. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study. Clin Exp Allergy. 2007 Sep. 37(9):1277-85. [QxMD MEDLINE Link].
Darsow U, Forer I, Ring J. Allergen-specific immunotherapy in atopic eczema. Curr Allergy Asthma Rep. 2011 Aug. 11(4):277-83. [QxMD MEDLINE Link].
Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol. 2011 Jan. 127(1 Suppl):S1-55. [QxMD MEDLINE Link].
Kiel MA, Röder E, Gerth van Wijk R, Al MJ, Hop WC, Rutten-van Mölken MP. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. J Allergy Clin Immunol. 2013 Aug. 132(2):353-60.e2. [QxMD MEDLINE Link].
Bernstein IL, Li JT, Bernstein DI, Hamilton R, Spector SL, Tan R, et al. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol. 2008 Mar. 100(3 Suppl 3):S1-148. [QxMD MEDLINE Link].
Webber CM, Calabria CW. Assessing the safety of subcutaneous immunotherapy dose adjustments. Ann Allergy Asthma Immunol. 2010 Nov. 105(5):369-75. [QxMD MEDLINE Link].
Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med. 1999 Aug 12. 341(7):468-75. [QxMD MEDLINE Link].
Eng PA, Borer-Reinhold M, Heijnen IA, Gnehm HP. Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood. Allergy. 2006 Feb. 61(2):198-201. [QxMD MEDLINE Link].
Des Roches A, Paradis L, Knani J, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. V. Duration of the efficacy of immunotherapy after its cessation. Allergy. 1996 Jun. 51(6):430-3. [QxMD MEDLINE Link].
Lane AP, Pine HS, Pillsbury HC 3rd. Allergy testing and immunotherapy in an academic otolaryngology practice: a 20-year review. Otolaryngol Head Neck Surg. 2001 Jan. 124(1):9-15. [QxMD MEDLINE Link].
Durham SR, Walker SM, Varga EM, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med. 1999 Aug 12. 341(7):468-75. [QxMD MEDLINE Link].
Ipsen H, Schwartz B, Wihl JA, et al. Immunotherapy with partially purified and standardized tree pollen extracts. III. Specific IgE response to the major allergens of alder, birch and hazel pollen during immunotherapy. Allergy. 1988 Jul. 43(5):370-7. [QxMD MEDLINE Link].
Veling MC, Trevino RJ. The treatment of allergic rhinitis with immunotherapy: a review of 1,000 cases. Ear Nose Throat J. 2001 Aug. 80(8):542-3. [QxMD MEDLINE Link].
Walker SM, Varney VA, Gaga M, Jacobson MR, Durham SR. Grass pollen immunotherapy: efficacy and safety during a 4-year follow-up study. Allergy. 1995 May. 50(5):405-13. [QxMD MEDLINE Link].
Shakir EM, Cheung DS, Grayson MH. Mechanisms of immunotherapy: a historical perspective. Ann Allergy Asthma Immunol. 2010 Nov. 105(5):340-7; quiz 348, 368. [QxMD MEDLINE Link].
Finegold I, Oppenheimer J. Immunotherapy: the next 100 years. Ann Allergy Asthma Immunol. 2010 Nov. 105(5):394-8. [QxMD MEDLINE Link].
Medscape. FDA OKs Oralair, First US Sublingual Allergy Immunotherapy. [Full Text].
Maloney J, Bernstein DI, Nelson H, Creticos P, Hébert J, Noonan M, et al. Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial. Ann Allergy Asthma Immunol. 2014 Feb. 112 (2):146-153.e2. [QxMD MEDLINE Link].
Creticos PS, Esch RE, Couroux P, Gentile D, D'Angelo P, Whitlow B. Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2014 Mar. 133(3):751-8. [QxMD MEDLINE Link].
Creticos PS, Maloney J, Bernstein DI, Casale T, Kaur A, Fisher R. Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults. J Allergy Clin Immunol. 2013 May. 131(5):1342-9.e6. [QxMD MEDLINE Link].
Nolte H, Bernstein DI, Nelson HS, Kleine-Tebbe J, Sussman GL, Seitzberg D, et al. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2016 Dec. 138 (6):1631-1638. [QxMD MEDLINE Link].
Virchow JC, Backer V, Kuna P, Prieto L, Nolte H, Villesen HH, et al. Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial. JAMA. 2016 Apr 26. 315 (16):1715-25. [QxMD MEDLINE Link].
Swift D. Sublingual Immunotherapy Improves Dust Mite Allergy. Medscape Medical News. Available at http://www.medscape.com/viewarticle/862508. April 27, 2016; Accessed: September 26, 2016.
Akdis M. Immunologic responses to sublingual allergen immunotherapy. Clin Allergy Immunol. 2008. 21:71-86. [QxMD MEDLINE Link].
Berger WE. Treatment update: allergic rhinitis. Allergy Asthma Proc. 2001 Jul-Aug. 22(4):191-8. [QxMD MEDLINE Link].
Bernstein JA, Brandt D, Ratner P, Wheeler W. Assessment of a rhinitis questionnaire in a seasonal allergic rhinitis population. Ann Allergy Asthma Immunol. 2008 May. 100(5):512-3. [QxMD MEDLINE Link].
Bousquet J, Dahl R, Khaltaev N. Global alliance against chronic respiratory diseases. Allergy. 2007 Mar. 62(3):216-23. [QxMD MEDLINE Link].
Buist AS, Vollmer WM, Wilson SR, Frazier EA, Hayward AD. A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma. Am J Respir Crit Care Med. 2006 Nov 15. 174(10):1077-87. [QxMD MEDLINE Link].
Emanuel IA. A comparison of in-vitro allergy diagnostic assays. Ear Nose Throat J. 1990 Jan. 69(1):27-8, 30-4, 39-41. [QxMD MEDLINE Link].
Emanuel IA. In vitro testing for allergy diagnosis. Comparison of methods in common use. Otolaryngol Clin North Am. 1998 Feb. 31(1):27-34. [QxMD MEDLINE Link].
Fokkens WJ. Antigen-presenting cells in nasal allergy. Allergy. 1999 Nov. 54(11):1130-41. [QxMD MEDLINE Link].
Gaddoni G, Baldassari L, Zucchini A. A new patch test preparation of dust mites for atopic dermatitis. Contact Dermatitis. 1994 Aug. 31(2):132-3. [QxMD MEDLINE Link].
Gendo K, Larson EB. Evidence-based diagnostic strategies for evaluating suspected allergic rhinitis. Ann Intern Med. 2004 Feb 17. 140(4):278-89. [QxMD MEDLINE Link].
Gordon BR. Allergy skin tests and immunotherapy: comparison of methods in common use. Ear Nose Throat J. 1990 Jan. 69(1):47-54, 57-62. [QxMD MEDLINE Link].
Gordon BR. Allergy skin tests and immunotherapy: comparison of methods in common use. Ear Nose Throat J. 1990 Jan. 69(1):47-54, 57-62. [QxMD MEDLINE Link].
Gordon BR. Allergy skin tests for inhalants and foods. Comparison of methods in common use. Otolaryngol Clin North Am. 1998 Feb. 31(1):35-53. [QxMD MEDLINE Link].
Haugaard L, Dahl R, Jacobsen L. A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side effects. J Allergy Clin Immunol. 1993 Mar. 91(3):709-22. [QxMD MEDLINE Link].
Haydon RC. Allergic rhinitis--current approaches to skin and in vitro testing. Otolaryngol Clin North Am. 2008 Apr. 41(2):331-46, vii. [QxMD MEDLINE Link].
Hunt KJ, Valentine MD, Sobotka AK, Benton AW, Amodio FJ, Lichtenstein LM. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med. 1978 Jul 27. 299(4):157-61. [QxMD MEDLINE Link].
Isolauri E, Turjanmaa K. Combined skin prick and patch testing enhances identification of food allergy in infants with atopic dermatitis. J Allergy Clin Immunol. 1996 Jan. 97(1 Pt 1):9-15. [QxMD MEDLINE Link].
Kelso JM, Sodhi N, Gosselin VA, Yunginger JW. Diagnostic performance characteristics of the standard Phadebas RAST, modified RAST, and pharmacia CAP system versus skin testing. Ann Allergy. 1991 Nov. 67(5):511-4. [QxMD MEDLINE Link].
King HC. Skin endpoint titration. Still the standard?. Otolaryngol Clin North Am. 1992 Feb. 25(1):13-25. [QxMD MEDLINE Link].
King WP. Efficacy of a screening radioallergosorbent test. Arch Otolaryngol. 1982 Dec. 108(12):781-6. [QxMD MEDLINE Link].
Kniker WT. Multi-Test skin testing in allergy: a review of published findings. Ann Allergy. 1993 Nov. 71(5):485-91. [QxMD MEDLINE Link].
Kniker WT. Multi-Test skin testing in allergy: a review of published findings. Ann Allergy. 1993 Nov. 71(5):485-91. [QxMD MEDLINE Link].
Kniker WT, Hales SW, Lee LK. Diagnostic methods to demonstrate igE antibodies: skin testing techniques. Bull N Y Acad Med. 1981 Sep. 57(7):524-48. [QxMD MEDLINE Link]. [Full Text].
Krouse JH, Krouse HJ. Efficacy of immunotherapy based on skin end-point titration. Otolaryngol Head Neck Surg. 2000 Sep. 123(3):183-7. [QxMD MEDLINE Link].
Larenas-Linnemann D. Subcutaneous and sublingual immunotherapy in children: complete update on controversies, dosing, and efficacy. Curr Allergy Asthma Rep. 2008 Nov. 8(6):465-74. [QxMD MEDLINE Link].
Mabry RL. Blending skin endpoint titration and in vitro methods in clinical practice. Otolaryngol Clin North Am. 1992 Feb. 25(1):61-70. [QxMD MEDLINE Link].
Mabry RL. Skin endpoint titration. Mabry RL, Ed. Whealing responses. 2nd. New York, NY: Thieme Medical Publishers; 1994. 19-25.
Marogna M, Bruno M, Massolo A, Falagiani P. Long-lasting effects of sublingual immunotherapy for house dust mites in allergic rhinitis with bronchial hyperreactivity: A long-term (13-year) retrospective study in real life. Int Arch Allergy Immunol. 2007. 142(1):70-8. [QxMD MEDLINE Link].
Meltzer EO, Szwarcberg J, Pill MW. Allergic rhinitis, asthma, and rhinosinusitis: diseases of the integrated airway. J Manag Care Pharm. 2004 Jul-Aug. 10(4):310-7. [QxMD MEDLINE Link].
Nelson HS. Diagnostic procedures in allergy. I. Allergy skin testing. Ann Allergy. 1983 Oct. 51(4):411-8. [QxMD MEDLINE Link].
Nelson HS, Oppenheimer J, Buchmeier A, Kordash TR, Freshwater LL. An assessment of the role of intradermal skin testing in the diagnosis of clinically relevant allergy to timothy grass. J Allergy Clin Immunol. 1996 Jun. 97(6):1193-201. [QxMD MEDLINE Link].
Oranje AP, Van Gysel D, Mulder PG, Dieges PH. Food-induced contact urticaria syndrome (CUS) in atopic dermatitis: reproducibility of repeated and duplicate testing with a skin provocation test, the skin application food test (SAFT). Contact Dermatitis. 1994 Nov. 31(5):314-8. [QxMD MEDLINE Link].
Passalacqua G, Pawankar R, Baena-Cagnani CE, Canonica GW. Sublingual immunotherapy: where do we stand? Present and future. Curr Opin Allergy Clin Immunol. 2009 Feb. 9(1):1-3. [QxMD MEDLINE Link].
Pepys J. Skin tests. Br J Hosp Med. 1984 Sep. 32(3):120, 122, 124. [QxMD MEDLINE Link].
Perelmutter L, Emanuel I. Assessment of in vitro IgE testing to diagnose allergic disease. Ann Allergy. 1985 Dec. 55(6):762-6. [QxMD MEDLINE Link].
Poon AW, Goodman CS, Rubin RJ. In vitro and skin testing for allergy: comparable clinical utility and costs. Am J Manag Care. 1998 Jul. 4(7):969-85. [QxMD MEDLINE Link].
Prussin C, Metcalfe DD. 4. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol. 2003 Feb. 111(2 Suppl):S486-94. [QxMD MEDLINE Link].
Remy W, Siebenwirth J, Rakoski J. Skin test of inhalant allergens by topical iontophoretic delivery in comparison to common skin prick tests. Dermatology. 1995. 190(1):87. [QxMD MEDLINE Link].
Sharma HP, Wood RA, Bravo AR, Matsui EC. A comparison of skin prick tests, intradermal skin tests, and specific IgE in the diagnosis of mouse allergy. J Allergy Clin Immunol. 2008 Apr. 121(4):933-9. [QxMD MEDLINE Link].
Wood RA, Phipatanakul W, Hamilton RG, Eggleston PA. A comparison of skin prick tests, intradermal skin tests, and RASTs in the diagnosis of cat allergy. J Allergy Clin Immunol. 1999 May. 103(5 Pt 1):773-9. [QxMD MEDLINE Link].